🧠 May 2025 - CerebrumDAO Contributor Newsletter
Brains Helping Brains
Hi everyone,
This month we are happy to share that we are pioneering a decentralized, double-blind, placebo-controlled trial for memory support—driven by our DAO.
Upcoming our third meet the scientists on Tackling Neurodegeneration with Mito-protective agents, this time with Dr Luis Rios from Fission Bio, register here https://lu.ma/d8o2b2gp
🔑 Key Metrics
Treasury: $8.4M total value | Total Capital Deployed: $1.389m
40+ Total projects sourced | 6 Projects funded |3 IP-NFTs minted | 6 IP-NFTs in the pipeline
Discord Members 1950 | Active 108 | X Followers: 5223 | Substack Subs: 107
Events last month:
Tokens
$NEURON | Cerebrum DAO Governance Token | All time high: $0.00143 | Now: $0.00015 | FDV: $12.6M |
$FIDEL | Transfidelity for Protein Stability | Molecule Catalyst
$MITY - NEURON-Fission - Developing Revolutionary Treatments for Inflammatory Disease
🔍 Deal Sourcing Spotlight
This quarter, we doubled down on strategic outreach to the rare disease community. We presented CerebrumDAO’s mission and funding model to institutions including:
Eva Louise and Horst Köhler Foundation (Germany)
Ataxia UK
Niemann-Pick UK
Huntington’s Disease Society of America (HDSA)
Hereditary Disease Foundation
Trisomy 21 Research Society (Down syndrome)
From these efforts, we connected with four promising researchers and early-stage founders—and we’re excited to be featured in Ataxia UK’s next newsletter.
🧪 Project Pipeline Snapshot
We’ve now:
Sourced over 40 research projects
Funded 6 ventures and
Minted 3 IP-NFTs, with 6 more in the pipeline
Our current scientific dealflow includes partnerships with top institutions like Harvard, Yale, Stanford, and Chapman University. Highlights include:
🧠 SK Channels Project
Licensing with Chapman, UT Southwestern, and Northeastern to explore treatments for tremor and ataxia.
🧪 Galectin-3 for Alzheimer’s – Lund University
💊 Serotonin 2A receptor antagonists – for schizophrenia
🚪 Blood-Brain Barrier opening tech – Yale
🧬 Microglia Engineering – Stanford
🧫 Brain organoid R&D – MIT & Harvard
🔬 Funded Project Progress
🧰 What We’re Building as a DAO
✅ Protocols: Decentralized trial framework
📜 IP: Licensing deals + tokenized patents
📊 Data: Wearable + cognitive endpoints
📣 Visibility: DeSci symposium @ Swiss Biotech Days
🌐 Collaborators: Reputable Health, Yale, Chapman, Stanford, Sygnature Discovery, University of Basel
We're also building a Translational Neuroscience Product Working Group to design, test, and bring neurotech tools to market—faster, cheaper, and community-owned.
🚀 What’s Next
🔬 Scientific Symposium – coming this fall in Basel
📣 Expansion of Percepta to 12-month protocol
🧠 More IPT spinouts – 3 new US-based projects queued
🤝 CRO protocol for future decentralized trials
📊 xponetiq integration to generate continuous data from Percepta
💡 Get Involved
Here’s how you can contribute right now:
Fund a milestone (trials, IPs, biomarkers)
Contribute your skills (legal, regulatory, operations)
Scout scientists and projects for our pipeline
Build a spinout (ask us how to go from idea → IP → venture)
Want to help? Join our Discord or write us
Thank you for being part of a new kind of biotech engine—community-owned, impact-driven, and laser-focused on brain health.
Together, we’re prototyping the future of brain science.
🧠 With gratitude,
The CerebrumDAO Core Team